Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE Usefulness of IGH/TCR PCR studies in lymphoproliferative disorders with inconclusive clonality by flow cytometry. 23943305 2014
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE FcRγ(+) DN T cells also showed enhanced sensitivity to TCR restimulation-induced cell death (RICD) despite lacking Fas, suggesting that TCR stimulation of autoreactive T cells in vivo may serve to eliminate FcRγ(+) T cells and thus exert partial control over lymphoproliferative disease. 23313147 2013
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE The assessment of the presence of clonal lymphoproliferations via polymerase chain reaction (PCR)-based analysis of rearranged immunoglobulin (Ig) or T-cell receptor (TCR) genes is a valuable technique in the diagnosis of suspect lymphoproliferative disorders. 23296958 2013
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE Polymerase chain reaction analysis of TCR-γR is a useful method for distinguishing different clonal processes and is recommended when differentiation of primary and secondary lymphoproliferative disorders is required. 21844453 2011
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE TCR gene rearrangement is important in the diagnosis of clonality and used as markers to detect minimal residual disease in lymphoproliferative disorders. 21114900 2010
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE Analysis of Ig/TCR genomic V(D)J repertoires by PCR based lymphoid clonality analysis within a diagnostic setting allows distinction of clonal from reactive lymphoproliferative disorders, clonal tracking for evidence of tumor dissemination and follow-up, identification of a lymphoid origin in undiagnosed tumors and evaluation of clonal evolution. 19731811 2009
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE Clinical follow-up was available for 5 of 7 TUGSE cases with clonal TCR gene rearrangement for an average period of 1.75 years after the initial biopsy or excision, and there was no evidence of local recurrence or development of systemic T-cell lymphoproliferative disorder. 19846813 2009
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE TCR alpha beta+/CD4+ T-large granular lymphocyte (LGL) lymphocytosis is a subgroup of monoclonal T-LGL lymphoproliferative disorders that are different from the CD8+ TCR alpha beta T-LGL. 18361934 2008
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE This study summarizes the outcomes of PCR analysis of IgH and TCR gene rearrangements in 91 bioptic cases of lymphoproliferative disorders. 18190238 2008
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE This report highlights the importance of TCR gene rearrangement analysis in the diagnosis of unusual gastric inflammation, and the use of capillary electrophoresis based polymerase chain reaction in the follow up of lymphoproliferative disorders. 15509690 2004
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE Sixty cases with a confirmed histological diagnosis of a T-cell lymphoproliferative disorder and TCR gamma GR were identified in our lymphoma registry from 1995 to 2001. 12707372 2003
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE Fourth, other lymphoproliferative disorders that are associated with CTCL share the same TCR gene rearrangements and therefore arise as subclones of the original tumor. 11594579 2001
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE However, in approximately one third of the cases of this lymphoproliferative disease rearrangements of T-cell receptor (TCR) genes indicating clonal expansion of T cells are not detectable. 11337383 2001
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE Polymerase chain reaction amplification of DNA for T-cell receptor (TCR) gene rearrangement analysis is helpful in the evaluation of T-cell lymphoproliferative disorders. 11175635 2001
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE Therefore, rearrangement of the Ig, T-cell receptor (TCR) genes, and surface markers are generally considered as useful markers of the B- and T-cell lineage in lymphoproliferative disorders. 10905058 2000
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE We conclude that nonradioactive PCR-SSCP for TCR-gamma gene rearrangement analysis is a useful adjunct to routine histological and immunophenotypic methods in the diagnosis of T-cell lymphoproliferative disorders in paraffin-embedded tissue. 9916920 1999
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE We have identified a YAC encompassing 70% of the TCR alpha/delta locus, which has been used as a fluorescence in situ hybridization probe to detect chromosome rearrangements involving 14q11, both at metaphase and within interphase nuclei, in patients with a variety of T-lymphoproliferative disorders. 9242557 1997
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE Clinical utility of heteroduplex analysis of TCR gamma gene rearrangements in the diagnosis of T-cell lymphoproliferative disorders. 9291458 1997
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 GeneticVariation group BEFREE The analysis of the configuration of the immunoglobulin (Ig) and T-cell receptor (TCR) gene regions has been of great relevance in defining conclusively the nature of several lymphoproliferative disorders in man. 1890861 1991
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE We also examined briefly the participation of immunoglobulin and TCR genes in chromosomal aberrations present in many lymphoproliferative disorders, often involving protooncogenes and potentially of tumorigenic consequences. 2247756 1990
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE Rearrangement of the immunoglobulin (Ig) and T-cell receptor (TcR) genes generally has been considered a useful marker of B- and T-cell lineage in lymphoproliferative disorders. 2331523 1990
CUI: C0024314
Disease: Lymphoproliferative Disorders
Lymphoproliferative Disorders
0.100 Biomarker group BEFREE We have studied the arrangement of the alpha, beta and gamma T cell receptor (TCR) genes in 27 patients with T cell lymphoproliferative disorders. 2961364 1987